Both in Pharmaceuticals
Bolt Biotherapeutics vs Neuphoria Therapeutics
Over the past year BOLT returned +11.8% and NEUP returned −30.6%; their daily moves had a correlation of 0.06.
BOLT +11.8% NEUP −30.6%Growth of $1, one year, split-adjusted
| Metric | BOLT | NEUP |
|---|---|---|
| Price | $6.24 | $3.04 |
| Market cap | $14.7M | $16.5M |
| Today | −5.31% | −0.33% |
| 1 month | +80.9% | −12.4% |
| 6 months | +23.3% | −42.5% |
| Year to date | +14.1% | −21.6% |
| 1 year | +8.9% | −30.9% |
| Revenue growth (YoY) | −99.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −154400.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $17.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 112.1% | 27.7% |
| Short % of float | 1.1% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).